So he wanted to produce molecules that activated only the AT2 receptor but not the other receptor, the AT1 receptor, as this would instead lead to problems such as an unwanted rise in blood pressure.

Co. Ltd. has developed new heterocyclic compounds acting as angiotensin AT2 receptor antagonists reported to be useful for the treatment of neuropathy and neuropathic pain.